Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur Rev Med Pharmacol Sci ; 28(9): 3455-3462, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38766798

RESUMEN

OBJECTIVE: Our study aims to determine the frequency and types of GTD (Gestational Trophoblastic Disease) in our clinic, to evaluate its relationship with clinical parameters, and the consistency of clinical prediagnosis and pathological definitive diagnosis. PATIENTS AND METHODS: In the present study, hospital records of 120 patients with gestational trophoblastic disease between January 2019 and August 2022 were obtained and evaluated retrospectively. Demographic, hematological, biochemical, and clinical data were collected in detail, and the data were analyzed statistically. RESULTS: Our study included a total of 120 female patients, with an average age of 31.16±9.70. The average number of patients was 3. The average time for women to receive the diagnosis was 9.80±2.45 weeks, with the most frequent complaint on our part being bleeding (85.8%). When the pathology outcomes of the patients we included in our study were examined, it was found that the number of patients diagnosed with incomplete abortion was 34, the number of patients diagnosed with complete abortion was 82, the number of invasive moles diagnosed was 3, and the number of patient diagnosed with choriocarcinoma was 1. Kappa ratio was calculated as 0.419 (p<0.001) when the compliance of the clinical diagnosis was assessed. This value was consistent with median level alignment. In a study that examined the three years of our calism in our bulk, 1.8 per 1,000 births were followed frequently. CONCLUSIONS: We should inform patients in detail about gestational trophoblastic diseases and warn patients not to delay their consequences. We should recommend that pregnancy be avoided for 12 months for low-risk patients and 18 months for high-risk patients after GTD.


Asunto(s)
Enfermedad Trofoblástica Gestacional , Humanos , Femenino , Enfermedad Trofoblástica Gestacional/diagnóstico por imagen , Enfermedad Trofoblástica Gestacional/diagnóstico , Embarazo , Estudios Retrospectivos , Adulto , Adulto Joven
2.
Eur Radiol ; 8(8): 1422-4, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9853228

RESUMEN

The US, CT, and X-ray findings in a patient with omental fibroma of the lesser omentum are described. Ultrasound showed a solid mass with cystic areas in the central region. At CT the lesion showed peripheral enhancement and central hypodensity. On X-ray studies with barium, there was border distortion in the lesser curvature of the stomach. The mass was resected surgically. A pathologic diagnosis of fibroma was confirmed.


Asunto(s)
Fibroma/diagnóstico , Epiplón/diagnóstico por imagen , Neoplasias Peritoneales/diagnóstico , Tomografía Computarizada por Rayos X , Anciano , Femenino , Fibroma/cirugía , Humanos , Laparotomía , Epiplón/cirugía , Neoplasias Peritoneales/cirugía , Radiografía Abdominal , Ultrasonografía
3.
Nephron ; 78(2): 207-11, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9496739

RESUMEN

Enzymatic antioxidant defense system and antioxidant defense potential (AOP) were studied in kidney tissue from rabbits treated with cyclosporine (CsA, 25 mg/kg/day), antioxidant vitamins (E, 100 mg/kg/day plus C, 200 mg/ kg/day), and CsA plus antioxidant vitamins, and in kidney tissue from control animals. Although no change was observed in superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-Px) and catalase (CAT) activities were found decreased in kidney tissue exposed to CsA for 10 days compared with control tissue. The level of thiobarbituric acid-reagent substances (TBARS) was higher and antioxidant defense potential (AOP) lower in the CsA-treated group compared with the other groups. Histopathological examination reveals important subcellular damage in the renal tissue from the animals treated with CsA. Antioxidant vitamin therapy caused full improvement in the enzyme activities, TBARS levels and AOP, but the subcellular damage was partly ameliorated in the CsA plus vitamin group. Results suggest that CsA impairs the antioxidant defense system and reduces the antioxidant defense potential in the renal tissue. Antioxidant vitamin treatment protects the tissue in part against toxic effects of the drug.


Asunto(s)
Antioxidantes/metabolismo , Ciclosporinas/farmacología , Inhibidores Enzimáticos/farmacología , Enfermedades Renales/prevención & control , Riñón/efectos de los fármacos , Riñón/enzimología , Animales , Ácido Ascórbico/administración & dosificación , Ácido Ascórbico/uso terapéutico , Catalasa/antagonistas & inhibidores , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Ciclosporina , Quimioterapia Combinada , Glutatión Peroxidasa/antagonistas & inhibidores , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Riñón/patología , Enfermedades Renales/inducido químicamente , Glomérulos Renales/citología , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/patología , Malondialdehído/metabolismo , Conejos , Superóxido Dismutasa/antagonistas & inhibidores , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Vitamina E/administración & dosificación , Vitamina E/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA